Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

BACKGROUND: COVID-19 vaccines have proven highly effective among individuals without a previous SARS-CoV-2 infection, but their effectiveness in preventing symptomatic infection and severe outcomes among individuals with previous infection is less clear. We aimed to estimate the effectiveness of fou...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerqueira-Silva, Thiago, Andrews, Jason R, Boaventura, Viviane S, Ranzani, Otavio T, de Araújo Oliveira, Vinicius, Paixão, Enny S, Júnior, Juracy Bertoldo, Machado, Tales Mota, Hitchings, Matt D T, Dorion, Murilo, Lind, Margaret L, Penna, Gerson O, Cummings, Derek A T, Dean, Natalie E, Werneck, Guilherme Loureiro, Pearce, Neil, Barreto, Mauricio L, Ko, Albert I, Croda, Julio, Barral-Netto, Manoel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971277/
https://www.ncbi.nlm.nih.gov/pubmed/35366959
http://dx.doi.org/10.1016/S1473-3099(22)00140-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971277/
https://www.ncbi.nlm.nih.gov/pubmed/35366959
http://dx.doi.org/10.1016/S1473-3099(22)00140-2

Ejemplares similares